Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 in Active Eosinophilic Esophagitis
NCT01056783Phase 2Completed
- Sponsor
- Oxagen
- Start
- Aug 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timapiprant in eosinophilic esophagitis (EoE), sponsored by Oxagen. Started Aug 2010; status: completed.
02
Drugs
timapiprant
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT01056783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056783.